Status:
COMPLETED
Intravitreal Injection Anesthesia - Comparison of Different Topical Agents
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Age-Related Macular Degeneration (AMD)
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Patients with neovascular age-related macular degeneration (AMD) scheduled to receive intravitreal (IVT) Ranibizumab injection will be randomized to receive one of three topical anesthetics: (1) tetra...
Detailed Description
All patients scheduled to receive intravitreal Ranibizumab for the treatment of neovascular AMD will be evaluated for inclusion into the study. After a positive evaluation, the study will be explained...
Eligibility Criteria
Inclusion
- Age greater than 50
- Scheduled to receive Ranibizumab for neovascular AMD
Exclusion
- History of pars plana vitrectomy
- Any major surgery within the prior 28 days, or one planned within next 6 months
- History of thromboembolic event
- Previous known allergic response to topical anesthetic(s) (lidocaine, tetracaine, cocaine)
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT01224847
Start Date
October 1 2009
End Date
November 1 2009
Last Update
April 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ivey Eye Institute
London, Ontario, Canada, N6A 4V2